Table IV.
NWR | NLR | |||||
---|---|---|---|---|---|---|
Variables | <0.67 | ≥0.67 | P-value | <2.85 | ≥2.85 | P-value |
Age | ||||||
<60 years | 77 | 51 | 75 | 53 | ||
≥60 years | 91 | 49 | 0.413 | 90 | 50 | 0.330 |
Sex | ||||||
Male | 95 | 66 | 91 | 70 | ||
Female | 73 | 34 | 0.156 | 74 | 33 | 0.041 |
Stage | ||||||
III | 26 | 20 | 28 | 18 | ||
IV | 142 | 80 | 0.403 | 137 | 85 | 0.915 |
Histological type | ||||||
Adeno | 144 | 81 | 140 | 85 | ||
Sqcc | 24 | 19 | 0.308 | 25 | 18 | 0.612 |
Smoking history | ||||||
None | 86 | 47 | 85 | 48 | ||
Yes | 82 | 53 | 0.507 | 80 | 55 | 0.434 |
ECOG PS | ||||||
0 | 153 | 85 | 151 | 87 | ||
Others | 15 | 15 | 0.161 | 14 | 16 | 0.110 |
Tumor location | ||||||
Left | 70 | 42 | 67 | 45 | ||
Right | 98 | 58 | 0.957 | 98 | 58 | 0.619 |
Adeno, adenocarcinoma; ECOG PS, Eastern Cooperative Oncology Group performance score; NLR, neutrophil/lymphocyte ratio; NWR, neutrophil/white blood cell ratio; Sqcc, squamous cell carcinoma.